Niosome-Based Approach for In Situ Gene Delivery to Retina and Brain Cortex as Immune-Privileged Tissues
Open accessAbstract
Non-viral vectors have emerged as a promising alternative to viral gene delivery systems due to their safer profile. Among non-viral vectors, recently, niosomes have shown favorable properties for gene delivery, including low toxicity, high stability, and easy production. The three main components of niosome formulations include a cationic lipid that is responsible for the electrostatic interactions with the negatively charged genetic material, a non-ionic surfactant that enhances the long-term stability of the niosome, and a helper component that can be added to improve its physicochemical properties and biological performance. This review is aimed at providing recent information about niosome-based non-viral vectors for gene delivery purposes. Specially, we will discuss the composition, preparation methods, physicochemical properties, and biological evaluation of niosomes and corresponding nioplexes that result from the addition of the genetic material onto their cationic surface. Next, we will focus on the in situ application of such niosomes to deliver the genetic material into immune-privileged tissues such as the brain cortex and the retina. Finally, as future perspectives, non-invasive administration routes and different targeting strategies will be discussed.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Niosomes have shown limited success potential as non-viral gene delivery systems due to improved transfection efficiency, biocompatibility, and cellular uptake, in addition to effects on intracellular trafficking.
“Niosomes, which are comprised of uncharged single-chain surfactant and cholesterol94,95 have also shown limited success potential as non-viral gene delivery systems96–101 due to improved transfection efficiency, biocompatibility, and cellular uptake, in addition to effects on intracellular trafficking.102”
From Gene Therapy for Retinal Degenerative Diseases: Progress, Challenges, and Future Directions (2023) · cites this paper as [96]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Search-and-replace genome editing without double-strand breaks or donor DNA
Anzalone, A. V., Randolph, P. B., Davis, J. R., Sousa, A. A., Koblan, L. W., Levy, J. M., Chen, P. J., Wilson, C., Newby, G. A., Raguram, A., et al. (2019) · Nature · doi:10.1038/s41586-019-1711-4 · Cited by 4,767 · see citing works
Toxicity of cationic lipids and cationic polymers in gene delivery
Lv, H., Zhang, S., Wang, B., Cui, S., & Yan, J. (2006) · Journal of Controlled Release · doi:10.1016/j.jconrel.2006.04.014 · Cited by 2,286 · see citing works
Russell, S., Bennett, J., Wellman, J. A., Chung, D. C., Yu, Z.-F., Tillman, A., Wittes, J., Pappas, J., Elci, O., McCague, S., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31868-8 · Cited by 1,952 · see citing works
Dunbar, C. E., High, K. A., Joung, J. K., Kohn, D. B., Ozawa, K., & Sadelain, M. (2018) · Science · doi:10.1126/science.aan4672 · Cited by 1,410 · see citing works
The Mystery and Magic of Glia: A Perspective on Their Roles in Health and Disease
Barres, B. A. (2008) · Neuron · doi:10.1016/j.neuron.2008.10.013 · Cited by 1,352 · see citing works
Medawar, P. B. (1948) · PubMed · Cited by 1,084 · see citing works
Protein adsorption and cellular uptake of cerium oxide nanoparticles as a function of zeta potential
Patil, S. D., Sandberg, A., Heckert, E. G., Self, W. T., & Seal, S. (2007) · Biomaterials · doi:10.1016/j.biomaterials.2007.07.029 · Cited by 1,045 · see citing works
Polyethylenimine-based non-viral gene delivery systems
Lungwitz, U., Breunig, M., Blunk, T., & Göpferich, A. M. (2005) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2004.11.011 · Cited by 985 · see citing works
Genome editing with Cas9 in adult mice corrects a disease mutation and phenotype
Yin, H., Xue, W., Chen, S., Bogorad, R. L., Benedetti, E., Grompe, M., Koteliansky, V., Sharp, P. A., Jacks, T., & Anderson, D. G. (2014) · Nature Biotechnology · doi:10.1038/nbt.2884 · Cited by 951 · see citing works
Chitosan‐Functionalized Graphene Oxide as a Nanocarrier for Drug and Gene Delivery
Bao, H., Pan, Y., Yuan, P., Sahoo, N. G., Wu, T., Li, L., Li, J., & Gan, L. H. (2011) · Small · doi:10.1002/smll.201100191 · Cited by 895 · see citing works
Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease
Kim, J., Hu, C., Achkar, C. M. E., Black, L. E., Douville, J., Larson, A. A., Pendergast, M. K., Goldkind, S. F., Lee, E. A., Kuniholm, A., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1813279 · Cited by 835 · see citing works
Ocular immune privilege: therapeutic opportunities from an experiment of nature
Streilein, J. W. (2003) · Nature Reviews Immunology · doi:10.1038/nri1224 · Cited by 807 · see citing works
Nano-niosomes as nanoscale drug delivery systems: An illustrated review
Moghassemi, S., & Hadjizadeh, A. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2014.04.015 · Cited by 800 · see citing works
Size-dependent DNA Mobility in Cytoplasm and Nucleus
Lukács, G. L., Haggie, P. M., Seksek, O., Lechardeur, D., Freedman, N. D., & Verkman, A. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.3.1625 · Cited by 752 · see citing works
Antisense oligonucleotides: basic concepts and mechanisms.
Dias, N., & Stein, C. A. (2002) · PubMed · Cited by 744 · see citing works
State-of-the-art gene-based therapies: the road ahead
Kay, M. A. (2011) · Nature Reviews Genetics · doi:10.1038/nrg2971 · Cited by 672 · see citing works
Delivery strategies of the CRISPR-Cas9 gene-editing system for therapeutic applications
Liu, C., Zhang, L., Liu, H., & Cheng, K. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.09.012 · Cited by 607 · see citing works
Parkinson's disease: Mechanisms, translational models and management strategies
Raza, C., Anjum, R., & Shakeel, N. U. A. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.03.057 · Cited by 604 · see citing works
Advances of Non-Ionic Surfactant Vesicles (Niosomes) and Their Application in Drug Delivery
Ge, X., Wei, M., He, S., & Yuan, W. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11020055 · Cited by 579 · see citing works
Niosomes from 80s to present: The state of the art
Marianecci, C., Marzio, L. D., Rinaldi, F., Celia, C., Paolino, D., Alhaique, F., Esposito, S. A., & Carafa, M. (2013) · Advances in Colloid and Interface Science · doi:10.1016/j.cis.2013.11.018 · Cited by 536 · see citing works
Chen, S., Hanning, S. M., Falconer, J. R., Locke, M., & Wen, J. (2019) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2019.08.015 · Cited by 461 · see citing works
Recent advances in the development of gene delivery systems.
Sung, Y., & Kim, S. (2019) · Biomaterials Research · doi:10.1186/s40824-019-0156-z · Cited by 458 · see citing works
Gänger, S., & Schindowski, K. (2018) · Pharmaceutics · doi:10.3390/pharmaceutics10030116 · Cited by 447 · see citing works
Gao, J., Nutter, J., Liu, X., Guan, D., Huang, Y., Dye, D., & Rainforth, W. M. (2018) · Scientific Reports · doi:10.1038/s41598-018-25899-3 · Cited by 430 · see citing works
Non-viral delivery systems for CRISPR/Cas9-based genome editing: challenges and opportunities
Li, L., Hu, S., & Chen, X. (2018) · Biomaterials · doi:10.1016/j.biomaterials.2018.04.031 · Cited by 415 · see citing works
Niosomes: A Controlled and Novel Drug Delivery System
Rajera, R., Nagpal, K., Singh, S. K., & Mishra, D. N. (2011) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.34.945 · Cited by 415 · see citing works
Graphene Oxide–Polyethylenimine Nanoconstruct as a Gene Delivery Vector and Bioimaging Tool
Kim, H., Namgung, R., Singha, K., Oh, I., & Kim, W. J. (2011) · Bioconjugate Chemistry · doi:10.1021/bc200397j · Cited by 402 · see citing works
Squalene: A natural triterpene for use in disease management and therapy
Reddy, L. H., & Couvreur, P. (2009) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2009.09.005 · Cited by 399 · see citing works
Polymer-Functionalized Nanodiamond Platforms as Vehicles for Gene Delivery
Zhang, X., Chen, M. I.-C., Lam, R. T.-T., Xu, X., O̅sawa, E., & Ho, D. (2009) · ACS Nano · doi:10.1021/nn900865g · Cited by 393 · see citing works
Gene therapy progress and prospects: non-viral gene therapy by systemic delivery
Li, S.-D., & Huang, L. (2006) · Gene Therapy · doi:10.1038/sj.gt.3302838 · Cited by 392 · see citing works
Characterization of cationic lipid-protamine–DNA (LPD) complexes for intravenous gene delivery
Li, S., Rizzo, M., Bhattacharya, S. S., & Huang, L. (1998) · Gene Therapy · doi:10.1038/sj.gt.3300683 · Cited by 369 · see citing works
Formulation and in vitro assessment of minoxidil niosomes for enhanced skin delivery
Balakrishnan, P., Shanmugam, S., Lee, W. S., Lee, W. M., Kim, J. O., Oh, D. H., Kim, D., Kim, J. S., Yoo, B. K., Choi, H.-G., et al. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.04.020 · Cited by 367 · see citing works
Identification and Quantitation of Carotenoids and their Metabolites in the Tissues of the Human Eye
Bernstein, P. S., Khachik, F., Carvalho, L. S., Muir, G. J., Zhao, D.-Y., & Katz, N. B. (2001) · Experimental Eye Research · doi:10.1006/exer.2000.0954 · Cited by 366 · see citing works
Surfactant Effects on Lipid-Based Vesicles Properties
Bnyan, R., Khan, I., Ehtezazi, T., Saleem, I. Y., Gordon, S., O’Neill, F., & Roberts, M. (2018) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2018.01.005 · Cited by 321 · see citing works
Bakondi, B., Lv, W., Lü, B., Jones, M. K., Tsai, Y.-C., Kim, K. J., Levy, R., Akhtar, A. A., Breunig, J. J., Svendsen, C. N., et al. (2015) · Molecular Therapy · doi:10.1038/mt.2015.220 · Cited by 300 · see citing works
In vitro study of polyoxyethylene alkyl ether niosomes for delivery of insulin
Pardakhty, A., Varshosaz, J., & Rouholamini, A. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2006.08.002 · Cited by 292 · see citing works
Novel Hyaluronic Acid-Chitosan Nanoparticles for Ocular Gene Therapy
de la Fuente, M., Seijo, B. A., & Alonso, M. J. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-1077 · Cited by 288 · see citing works
Lipid bilayers: thermodynamics, structure, fluctuations, and interactions
Tristram‐Nagle, S., & Nagle, J. F. (2003) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2003.09.002 · Cited by 281 · see citing works
Niosomes as carriers for tretinoin
Manconi, M., Sinico, C., Valenti, D., Lai, F., & Fadda, A. M. (2006) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.11.045 · Cited by 277 · see citing works
Nanoemulsions for “Nose-to-Brain” Drug Delivery
Bonferoni, M. C., Rossi, S., Sandri, G., Ferrari, F., Gavini, E., Rassu, G., & Giunchedi, P. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11020084 · Cited by 269 · see citing works
Development and Clinical Translation of Approved Gene Therapy Products for Genetic Disorders
Shahryari, A., Jazi, M. S., Mohammadi, S., Nikoo, H. R., Nazari, Z., Hosseini, E. S., Burtscher, I., Mowla, S. J., & Lickert, H. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00868 · Cited by 266 · see citing works
Erbacher, P., Roche, A., Monsigny, M. L. P., & Midoux, P. (1996) · Experimental Cell Research · doi:10.1006/excr.1996.0169 · Cited by 252 · see citing works
Targeted Molecular Therapy of GBM
Mischel, P. S., & Cloughesy, T. F. (2003) · Brain Pathology · doi:10.1111/j.1750-3639.2003.tb00006.x · Cited by 245 · see citing works
Non-viral gene therapy: Gains and challenges of non-invasive administration methods
Földvári, M., Chen, D.-W., Nafissi, N., Calderon-Nieva, D., Narsineni, L., & Rafiee, A. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.12.012 · Cited by 240 · see citing works
Vectors and delivery systems in gene therapy.
Gardlík, R., Pálffy, R., Hodosy, J., Lukács, J., Turňa, J., & Celec, P. (2005) · PubMed · Cited by 219 · see citing works
Efficient tumor targeting of hydroxycamptothecin loaded PEGylated niosomes modified with transferrin
Hong, M., Zhu, S., Jiang, Y., Tang, G., & Pei, Y. (2008) · Journal of Controlled Release · doi:10.1016/j.jconrel.2008.09.005 · Cited by 218 · see citing works
Actin Cytoskeleton as the Principal Determinant of Size-dependent DNA Mobility in Cytoplasm
Dauty, E., & Verkman, A. S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412374200 · Cited by 215 · see citing works
Recent progress in nanomaterials for gene delivery applications
Keleş, E., Song, Y., Du, D., Dong, W., & Lin, Y. (2016) · Biomaterials Science · doi:10.1039/c6bm00441e · Cited by 213 · see citing works
Distribution of nerve growth factor following direct delivery to brain interstitium
Krewson, C. E., Klarman, M. L., & Saltzman, W. M. (1995) · Brain Research · doi:10.1016/0006-8993(95)00261-n · Cited by 201 · see citing works
Vitreous: A Barrier to Nonviral Ocular Gene Therapy
Peeters, L., Sanders, N. N., Braeckmans, K., Boussery, K., Van de Voorde, J., De Smedt, S. C., & Demeester, J. (2005) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.05-0165 · Cited by 189 · cited 1× · see citing works
“Consequently, to enhance such interaction, protamine was incorporated in lipid formulations such as SLNs [135] or liposomes [136] but not in niosomes for retinal gene delivery.”
BackgroundProgress and Prospects: The design and production of plasmid vectors
Gill, D. R., Pringle, I. A., & Hyde, S. C. (2009) · Gene Therapy · doi:10.1038/gt.2008.183 · Cited by 188 · see citing works
Vector platforms for gene therapy of inherited retinopathies
Trapani, I., Puppo, A., & Auricchio, A. (2014) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2014.08.001 · Cited by 184 · see citing works
Mathias, N. R., & Hussain, M. A. (2009) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.21793 · Cited by 183 · see citing works
Luzio, J. P., Gray, S. R., & Bright, N. A. (2010) · Biochemical Society Transactions · doi:10.1042/bst0381413 · Cited by 179 · see citing works
Phagocytic glial cells: sculpting synaptic circuits in the developing nervous system
Schafer, D. P., & Stevens, B. (2013) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2013.09.012 · Cited by 174 · see citing works
Manosroi, A., Jantrawut, P., & Manosroi, J. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.04.033 · Cited by 171 · see citing works
A novel cationic niosome formulation for gene delivery to the retina
Puras, G., Mashal, M., Zárate, J., Agirre, M., Ojeda, E., Grijalvo, S., Eritja, R., Diaz-Tahoces, A., Martínez Navarrete, G., Avilés-Trigueros, M., et al. (2014) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.11.004 · Cited by 164 · see citing works
Self-citationGene Therapy Tools for Brain Diseases
Ingusci, S., Verlengia, G., Soukupova, M., Zucchini, S., & Simonato, M. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.00724 · Cited by 158 · see citing works
Barani, M., Mirzaei, M., Torkzadeh‐Mahani, M., & Nematollahi, M. H. (2018) · DARU Journal of Pharmaceutical Sciences · doi:10.1007/s40199-018-0207-3 · Cited by 155 · see citing works
Sucrose stearate-based proniosome-derived niosomes for the nebulisable delivery of cromolyn sodium
Abdelbary, A., El-Laithy, H. M., & Tadros, M. I. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.01.056 · Cited by 148 · see citing works
Piazzini, V., Landucci, E., D’Ambrosio, M., Fasiolo, L. T., Cinci, L., Colombo, G., Pellegrini-Giampietro, D. E., Bilia, A. R., Luceri, C., & Bergonzi, M. C. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2019.02.005 · Cited by 147 · see citing works
Delivery of CRISPR/Cas9 for therapeutic genome editing
Xu, X., Wan, T. Y., Xin, H., Li, D., Pan, H., Wu, J., & Yuan, P. (2019) · The Journal of Gene Medicine · doi:10.1002/jgm.3107 · Cited by 147 · see citing works
Kashyap, K., & Shukla, R. (2019) · Current Drug Delivery · doi:10.2174/1567201816666191029122740 · Cited by 146 · see citing works
The privileged immunity of immune privileged organs: the case of the eye
Benhar, I., London, A., & Schwartz, M. (2012) · Frontiers in Immunology · doi:10.3389/fimmu.2012.00296 · Cited by 144 · see citing works
Proniosomes derived niosomes: recent advancements in drug delivery and targeting
Khatoon, M., Shah, K. U., Din, F. U., Shah, S. U., Rehman, A. U., Dilawar, N., & Khan, A. N. (2017) · Drug Delivery · doi:10.1080/10717544.2017.1384520 · Cited by 135 · see citing works
Vaughan, E. E., DeGiulio, J. V., & Dean, D. A. (2006) · Current Gene Therapy · doi:10.2174/156652306779010688 · Cited by 123 · see citing works
Therapeutic gene editing: delivery and regulatory perspectives
Shim, G., Kim, D., Park, G. T., Jin, H., Suh, S., & Oh, Y. (2017) · Acta Pharmacologica Sinica · doi:10.1038/aps.2017.2 · Cited by 121 · see citing works
Arafa, M. G., Ghalwash, D. M., El‐Kersh, D. M., & Elmazar, M. M. (2018) · Scientific Reports · doi:10.1038/s41598-018-37157-7 · Cited by 121 · see citing works
Non-viral delivery of genome-editing nucleases for gene therapy
Wang, M., Glass, Z., & Xu, Q. (2016) · Gene Therapy · doi:10.1038/gt.2016.72 · Cited by 110 · see citing works
Liposomes produced by microfluidics and extrusion: A comparison for scale-up purposes
Shah, V. M., Nguyen, D. X., Patel, P. B., Cote, B., Fatease, A. M. A., Pham, Y., Huynh, M. G., Woo, Y., & Alani, A. W. G. (2019) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2019.02.019 · Cited by 106 · see citing works
Biophysical and lipofection studies of DOTAP analogs
Regelin, A. E., Fankhaenel, S., Gürtesch, L., Prinz, C., von Kiedrowski, G., & Massing, U. (2000) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(00)00126-7 · Cited by 105 · see citing works
del Pozo‐Rodríguez, A., Delgado, D., Solinís, M. Á., Rodríguez‐Gascón, A., & Pedraz, J. L. (2008) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2008.04.023 · Cited by 100 · see citing works
Self-citationKassem, A. A., El-Alim, S. H. A., & Asfour, M. H. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.12.018 · Cited by 100 · see citing works
Pilipenko, I., Korzhikov-Vlakh, V. A., Sharoyko, V. V., Zhang, N., Schäfer‐Korting, M., Rühl, E., Zoschke, C., & Tennikova, T. B. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11070317 · Cited by 99 · see citing works
Topical drug delivery to retinal pigment epithelium with microfluidizer produced small liposomes
Lajunen, T., Hisazumi, K., Kanazawa, T., Okada, H., Seta, Y., Yliperttula, M. L., Urtti, A. O., & Takashima, Y. (2014) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2014.04.018 · Cited by 98 · see citing works
Gene Therapy for the Nervous System: Challenges and New Strategies
Maguire, C. A., Ramirez, S. H., Merkel, S. F., Sena‐Esteves, M., & Breakefield, X. O. (2014) · Neurotherapeutics · doi:10.1007/s13311-014-0299-5 · Cited by 96 · see citing works
Zhang, Y., Schlachetzki, F., Li, J. Y., Boado, R. J., & Pardridge, W. M. (2003) · PubMed · Cited by 95 · see citing works
Grijalvo, S., Puras, G., Sesma, J. Z., Sainz-Ramos, M., Qtaish, N. A., López-Méndez, T. B., Mashal, M., Attia, N., Díaz, D. D., Pons, R., et al. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11020050 · Cited by 95 · see citing works
Self-citationFalconer, R. (2016) · Journal of Molecular Recognition · doi:10.1002/jmr.2550 · Cited by 94 · see citing works
Current status of non-viral gene therapy for CNS disorders
Jayant, R. D., Sosa, D., Kaushik, A. K., Atluri, V. S. R., Vashist, A., Tomitaka, A., & Nair, M. (2016) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2016.1188802 · Cited by 91 · see citing works
Biomaterials as vectors for the delivery of CRISPR–Cas9
Eoh, J. H., & Gu, L. (2019) · Biomaterials Science · doi:10.1039/c8bm01310a · Cited by 91 · see citing works
A Novel Cationic Amphiphile for Transfection of Mammalian Cells
Ruysschaert, J., Elouahabi, A., Willeaume, V., Huez, G. A., Fuks, R., Vandenbranden, M., & DiStefano, P. S. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.2372 · Cited by 91 · see citing works
Barani, M., Nematollahi, M. H., Zaboli, M., Mirzaei, M., Torkzadeh‐Mahani, M., Pardakhty, A., & Asadikaram, G. (2018) · Materials Science and Engineering C · doi:10.1016/j.msec.2018.09.026 · Cited by 91 · see citing works
RNA major groove modifications improve siRNA stability and biological activity
Terrazas, M., & Kool, E. T. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn958 · Cited by 90 · see citing works
Yeste, J., García-Ramírez, M., Illa, X., Guimerà, A., Hernández, C., Simó, R., & Villa, R. (2018) · Lab on a Chip · doi:10.1039/c7lc00795g · Cited by 89 · cited 1× · see citing works
“In the case of immune-privileged organs such as the brain and eye, in addition to culture cells, different and sophisticated in vitro models based on microfluidic chips of both the BBB and BRB can be used to better mimic the in vivo conditions and predict their behavior performance [117,118].”
BackgroundGu, J., Ge, J., Li, M., Xu, H., Wu, F., & Qin, Z. (2013) · PLoS ONE · doi:10.1371/journal.pone.0061641 · Cited by 89 · see citing works
Comparative Analysis of DNA Nanoparticles and AAVs for Ocular Gene Delivery
Han, Z., Conley, S. M., Makkia, R. S., Guo, J., Cooper, M. J., & Naash, M. I. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052189 · Cited by 84 · see citing works
Masuda, T., Akita, H., & Harashima, H. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.02.071 · Cited by 82 · see citing works
Gene therapy for ocular diseases
Liu, M. M., Tuo, J., & Chan, C.-C. (2011) · British Journal of Ophthalmology · doi:10.1136/bjo.2009.174912 · Cited by 82 · see citing works
Gene Transfer: How Can the Biological Barriers Be Overcome?
Escoffre, J., Teissié, J., & Rols, M. (2010) · Journal of Membrane Biology · doi:10.1007/s00232-010-9275-0 · Cited by 79 · see citing works
Alexander, A., & Saraf, S. (2018) · Neural Regeneration Research · doi:10.4103/1673-5374.241458 · Cited by 77 · see citing works
del Pozo‐Rodríguez, A., Delgado, D., Solinís, M. Á., Pedraz, J. L., Echevarrı́a, E., Rodríguez, J. M., & Rodríguez‐Gascón, A. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.10.020 · Cited by 74 · see citing works
Self-citationOjeda, E., Puras, G., Agirre, M., Sesma, J. Z., Grijalvo, S., Eritja, R., Martı́nez, G., Soto‐Sánchez, C., Díaz‐Tahoces, A., Avilés‐Trigueros, M., et al. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.11.017 · Cited by 74 · see citing works
Self-citationMashal, M., Attia, N., Puras, G., Martínez-Navarrete, G., Fernández, E., & Pedraz, J. L. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.03.386 · Cited by 74 · see citing works
Self-citationEx vivo gene therapy for the treatment of neurological disorders
Gowing, G., Svendsen, S. P., & Svendsen, C. N. (2017) · Progress in brain research · doi:10.1016/bs.pbr.2016.11.003 · Cited by 72 · see citing works
A review of therapeutic prospects of non-viral gene therapy in the retinal pigment epithelium
Koirala, A., Conley, S. M., & Naash, M. I. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.06.002 · Cited by 71 · see citing works
Gene Therapy, Early Promises, Subsequent Problems, and Recent Breakthroughs
Soofiyani, S. R., Baradaran, B., Lotfipour, F., Kazemi, T., & Mohammadnejad, L. (2013) · Europe PMC (PubMed Central) · doi:10.5681/apb.2013.041 · Cited by 70 · see citing works
Anand, V., Duffy, B., Yang, Z., Dejneka, N. S., Maguire, A. M., & Bennett, J. (2002) · Molecular Therapy · doi:10.1006/mthe.2002.0525 · Cited by 69 · see citing works
ε-Poly-l-Lysine/plasmid DNA nanoplexes for efficient gene delivery in vivo
Mandal, H., Katiyar, S. S., Swami, R., Kushwah, V., Katare, P. B., Meka, A. K., Banerjee, S., Popat, A., & Jain, S. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.03.021 · Cited by 68 · see citing works
Do niosomes have a place in the field of drug delivery?
Muzzalupo, R., & Mazzotta, E. (2019) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2019.1663821 · Cited by 67 · see citing works
Bacterial DNA is implicated in the inflammatory response to delivery of DNA/DOTAP to mouse lungs
McLachlan, G., Stevenson, B., Davidson, D. J., & Porteous, D. J. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301097 · Cited by 65 · see citing works
Ying, L., Tahara, K., & Takeuchi, H. (2013) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2013.06.024 · Cited by 64 · see citing works
Lim, D. G., Rajasekaran, N., Lee, D., Kim, N. A., Jung, H. S., Hong, S., Shin, Y. K., Kang, E., & Jeong, S. H. (2017) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.7b09624 · Cited by 61 · see citing works
Stability Studies on Piroxicam Encapsulated Niosomes
Ertekіn, Z. C., Bayındır, Z. S., & Yüksel, N. (2015) · Current Drug Delivery · doi:10.2174/1567201811666140723115852 · Cited by 60 · see citing works
We still have a Long Way to go to Effectively Deliver Genes!
Pezzoli, D., Chiesa, R., Nardo, L. D., & Candiani, G. (2012) · Journal of Applied Biomaterials & Functional Materials · doi:10.5301/jabfm.2012.9707 · Cited by 58 · see citing works
Mashal, M., Attia, N., Martínez-Navarrete, G., Soto-Sánchez, C., Fernández, E., Grijalvo, S., Eritja, R., Puras, G., & Pedraz, J. L. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.05.010 · Cited by 58 · see citing works
Self-citationOjeda, E., Puras, G., Agirre, M., Sesma, J. Z., Grijalvo, S., Pons, R., Eritja, R., Martı́nez, G., Soto‐Sánchez, C., Fernández, E., et al. (2014) · Organic & Biomolecular Chemistry · doi:10.1039/c4ob02087a · Cited by 56 · see citing works
Self-citationPaying for future success in gene therapy
Orkin, S. H., & Reilly, P. R. (2016) · Science · doi:10.1126/science.aaf4770 · Cited by 56 · see citing works
O’Mahony, A., Godinho, B. M. D. C., Cryan, J. F., & O’Driscoll, C. M. (2013) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.23672 · Cited by 55 · see citing works
Gu, Y., Xu, C., Wang, Y., Zhou, X., Fang, L., & Cao, F. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b01136 · Cited by 53 · see citing works
Stem cell-based gene delivery mediated by cationic niosomes for bone regeneration
Attia, N., Mashal, M., Grijalvo, S., Eritja, R., Sesma, J. Z., Puras, G., & Pedraz, J. L. (2017) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2017.11.005 · Cited by 52 · see citing works
Self-citationAlqawlaq, S., Sivak, J. M., Huzil, J. T., Ivanova, M. V., Flanagan, J. G., Beazely, M. A., & Földvári, M. (2014) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2014.05.010 · Cited by 51 · see citing works
Has retinal gene therapy come of age? From bench to bedside and back to bench
Trapani, I., & Auricchio, A. (2019) · Human Molecular Genetics · doi:10.1093/hmg/ddz130 · Cited by 51 · see citing works
Zhang, X., Sawyer, G. J., Dong, X., Qiu, Y., Collins, L., & Fabre, J. W. (2002) · The Journal of Gene Medicine · doi:10.1002/jgm.340 · Cited by 50 · see citing works
Gallego, I., Villate-Beitia, I., Martı́nez, G., Menéndez, M., López-Méndez, T. B., Soto‐Sánchez, C., Sesma, J. Z., Puras, G., Fernández, E., & Pedraz, J. L. (2019) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2018.12.018 · Cited by 50 · see citing works
Self-citationLow molecular weight oligochitosans for non-viral retinal gene therapy
Puras, G., Sesma, J. Z., Aceves, M., Murua, A., Díaz‐Tahoces, A., Avilés‐Trigueros, M., Fernández, E., & Pedraz, J. L. (2012) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2012.09.010 · Cited by 49 · see citing works
Self-citationPuras, G., Martı́nez, G., Mashal, M., Sesma, J. Z., Agirre, M., Ojeda, E., Grijalvo, S., Eritja, R., Díaz‐Tahoces, A., Avilés‐Trigueros, M., et al. (2015) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00422 · Cited by 47 · see citing works
Self-citationKim, Y. J. (2003) · International Journal of Pharmaceutics · doi:10.1016/s0378-5173(02)00676-2 · Cited by 47 · see citing works
Kim, H., Man, H., Saha, B., Kopacz, A. M., Lee, O., Schatz, G. C., Ho, D., & Liu, W. K. (2012) · The Journal of Physical Chemistry Letters · doi:10.1021/jz301756e · Cited by 47 · see citing works
Chen, Y. H., Claflin, K. E., Geoghegan, J. C., & Davidson, B. L. (2012) · Molecular Therapy · doi:10.1038/mt.2012.100 · Cited by 46 · see citing works
RNA Therapeutics: How Far Have We Gone?
Coutinho, M. F., Matos, L., Santos, J. I., & Alves, S. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-19966-1_7 · Cited by 44 · see citing works
Global CNS gene transfer for a childhood neurogenetic enzyme deficiency: Canavan disease.
Leone, P., Janson, C. G., McPhee, S., & During, M. J. (1999) · PubMed · Cited by 42 · see citing works
Villate-Beitia, I., Gallego, I., Martínez-Navarrete, G., Zárate, J., López-Méndez, T., Soto-Sánchez, C., Santos-Vizcaíno, E., Puras, G., Fernández, E., & Pedraz, J. L. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.07.035 · Cited by 42 · see citing works
Self-citationCell Squeezing as a Robust, Microfluidic Intracellular Delivery Platform
Sharei, A., Cho, N., Mao, S., Jackson, E., Poceviciute, R., Adamo, A., Zoldan, J., Langer, R., & Jensen, K. F. (2013) · Journal of Visualized Experiments · doi:10.3791/50980 · Cited by 41 · see citing works
Nanodiamonds for bioapplications–specific targeting strategies
Terada, D., Genjo, T., Segawa, T. F., Igarashi, R., & Shirakawa, M. (2019) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2019.04.019 · Cited by 39 · see citing works
Oligochitosan polyplexes as carriers for retinal gene delivery
Puras, G., Sesma, J. Z., Díaz‐Tahoces, A., Avilés‐Trigueros, M., Fernández, E., & Pedraz, J. L. (2012) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2012.11.009 · Cited by 38 · see citing works
Self-citationOjeda, E., Puras, G., Agirre, M., Sesma, J. Z., Grijalvo, S., Eritja, R., Digiacomo, L., Caracciolo, G., & Pedraz, J. L. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.02.043 · Cited by 38 · see citing works
Self-citationBadea, I., Alwani, S., Kaur, R., Michel, D. L., Chitanda, J. M., Verrall, R. E., & Karunakaran, C. (2016) · International Journal of Nanomedicine · doi:10.2147/ijn.s92218 · Cited by 37 · see citing works
Akita, H., Tanimoto, M., Masuda, T., Kogure, K., Hama, S., Ninomiya, K., Futaki, S., & Harashima, H. (2005) · The Journal of Gene Medicine · doi:10.1002/jgm.839 · Cited by 36 · see citing works
Mashal, M., Attia, N., Soto‐Sánchez, C., Martı́nez, G., Fernández, E., Puras, G., & Pedraz, J. L. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.09.038 · Cited by 36 · see citing works
Self-citationAmphiphilic Polypeptides for VEGF siRNA Delivery into Retinal Epithelial Cells
Osipova, O., Sharoyko, V. V., Zashikhina, N., Захарова, Н. В., Tennikova, T. B., Urtti, A. O., & Korzhikova‐Vlakh, E. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12010039 · Cited by 36 · see citing works
Multimodal Imaging in Hereditary Retinal Diseases
Pichi, F., Morara, M., Veronese, C., Nucci, P., & Ciardella, A. P. (2013) · Journal of Ophthalmology · doi:10.1155/2013/634351 · Cited by 36 · see citing works
High transfection efficiency and low toxicity cationic lipids with aminoglycerol–diamine conjugate
Yingyongnarongkul, B., Radchatawedchakoon, W., Krajarng, A., Watanapokasin, R. Y., & Suksamrarn, A. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.11.003 · Cited by 36 · see citing works
From fiction to science: clinical potentials and regulatory considerations of gene editing
Schacker, M., & Seimetz, D. (2019) · Clinical and Translational Medicine · doi:10.1186/s40169-019-0244-7 · Cited by 35 · see citing works
Villate-Beitia, I., Truong, N. F., Gallego, I., Sesma, J. Z., Puras, G., Pedraz, J. L., & Segura, T. (2018) · RSC Advances · doi:10.1039/c8ra05125a · Cited by 35 · see citing works
Self-citationLiu, J., Guo, S., Li, Z., Liu, L., & Gu, J. (2009) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2009.04.026 · Cited by 33 · see citing works
Blood brain barrier: A tissue engineered microfluidic chip
Musafargani, S., Mishra, S., Gulyás, M., Mahalakshmi, P., Archunan, G., Padmanabhan, P., & Gulyás, B. Z. (2019) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2019.108525 · Cited by 32 · see citing works
Prediction of aqueous solubility from SCRATCH
Jain, P. K., & Yalkowsky, S. H. (2009) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2009.10.003 · Cited by 32 · see citing works
Edgington, R. J., Spillane, K. M., Papageorgiou, G., Wray, W., Ishiwata, H., Labarca, M., Leal‐Ortiz, S., Reid, G., Webb, M. R., Foord, J. S., et al. (2018) · Scientific Reports · doi:10.1038/s41598-017-18601-6 · Cited by 31 · see citing works
Ilina, P., Hyvönen, Z., Saura, M., Sandvig, K., Yliperttula, M. L., & Ruponen, M. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.09.016 · Cited by 29 · see citing works
Use of gene therapy in central nervous system repair
Tinsley, R. B., & Eriksson, P. S. (2004) · Acta Neurologica Scandinavica · doi:10.1046/j.1600-0404.2003.00240.x · Cited by 29 · see citing works
Clinical and experimental research in antituberculosis drug-induced hepatotoxicity: a review
Baskaran, U. L., & Prince, S. E. (2017) · Journal of Chinese Integrative Medicine · doi:10.1016/s2095-4964(17)60319-4 · Cited by 28 · see citing works
Torrecilla, J., del Pozo‐Rodríguez, A., Apaolaza, P. S., Solinís, M. Á., & Rodríguez‐Gascón, A. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.12.047 · Cited by 27 · see citing works
Cacciotti, I., Ceci, C., Bianco, A., & Pistritto, G. (2017) · Materials Science and Engineering C · doi:10.1016/j.msec.2017.07.033 · Cited by 27 · see citing works
In vivo methods for acute modulation of gene expression in the central nervous system
Cwetsch, A. W., Pinto, B., Savardi, A., & Cancedda, L. (2018) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2018.04.008 · Cited by 26 · see citing works
Duvshani‐Eshet, M., Keren, H., Oz, S., Radzishevsky, I. S., Mor, A., & Machluf, M. (2008) · The Journal of Gene Medicine · doi:10.1002/jgm.1235 · Cited by 25 · see citing works
Synthesis of Lipid–Oligonucleotide Conjugates for RNA Interference Studies
Grijalvo, S., Ocampo, S. M., Perales, J. C., & Eritja, R. (2011) · Chemistry & Biodiversity · doi:10.1002/cbdv.201000274 · Cited by 24 · see citing works
Self-citationImproving transfection efficiency of ultrapure oligochitosan/DNA polyplexes by medium acidification
Agirre, M., Sesma, J. Z., Puras, G., Ojeda, E., & Pedraz, J. L. (2014) · Drug Delivery · doi:10.3109/10717544.2013.871373 · Cited by 24 · see citing works
Self-citationOncolytic viruses: what to expect from their use in cancer treatment
Terrível, M. P., Gromicho, C., & Matos, A. M. (2019) · Microbiology and Immunology · doi:10.1111/1348-0421.12753 · Cited by 24 · see citing works
Ex Vivo Gene Therapy and Vision
Gregory-Evans, K., Bashar, E., & Tan, M. (2012) · Current Gene Therapy · doi:10.2174/156652312800099607 · Cited by 23 · see citing works
Liposomal and Viral Vectors for Gene Therapy of the Central Nervous System
de Lima, M. C. P., da Cruz, M. T. G., Cardoso, A. L., Simões, S., & de Almeida, L. P. (2005) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1568007054546144 · Cited by 23 · see citing works
Puras, G., Sesma, J. Z., Agirre, M., Díaz‐Tahoces, A., Avilés-Trigeros, M., Grijalvo, S., Eritja, R., Fernández, E., & Pedraz, J. L. (2014) · Pharmaceutical Research · doi:10.1007/s11095-013-1271-5 · Cited by 22 · see citing works
Self-citationPrimavera, R., Palumbo, P., Celia, C., Cinque, B., Carata, E., Carafa, M., Paolino, D., Cifone, M. G., & Marzio, L. D. (2018) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2018.03.013 · Cited by 22 · see citing works
Zhang, T., Ma, J., Li, C., Lin, K. Y., Lou, F., Jiang, H., Gao, Y., Yang, Y., Ming, C., & Ruan, B. (2017) · Oncology Reports · doi:10.3892/or.2017.5365 · Cited by 22 · see citing works
Agirre, M., Ojeda, E., Sesma, J. Z., Puras, G., Grijalvo, S., Eritja, R., del Caño, G. G., Barrondo, S., González‐Burguera, I., de Jesús, M. L., et al. (2015) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.5b00496 · Cited by 21 · see citing works
Self-citationEndocytosis in gene therapy with non-viral vectors
de Garibay, A. P. R. (2016) · Wiener Medizinische Wochenschrift · doi:10.1007/s10354-016-0450-5 · Cited by 21 · see citing works
Ojeda, E., Agirre, M., Villate-Beitia, I., Mashal, M., Puras, G., Sesma, J. Z., & Pedraz, J. L. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-3718-9_5 · Cited by 21 · see citing works
Self-citationPlasmid-based gene transfer ameliorates visceral storage in a mouse model of Sandhoff disease
Yamaguchi, A., Katsuyama, K., Suzuki, K., Kosaka, K., Aoki, I., & Yamanaka, S. (2003) · Journal of Molecular Medicine · doi:10.1007/s00109-002-0410-y · Cited by 21 · see citing works
Non‐viral nucleic acid delivery to the central nervous system and brain tumors
Wang, S., & Huang, R. (2019) · The Journal of Gene Medicine · doi:10.1002/jgm.3091 · Cited by 19 · see citing works
Grijalvo, S., Alagia, A., Puras, G., Sesma, J. Z., Pedraz, J. L., & Eritja, R. (2014) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2014.04.016 · Cited by 18 · see citing works
Self-citationRegulation of Endocytosis by Non-Viral Vectors for Efficient Gene Activity
Islam, M. A., Firdous, J., Choi, Y., Yun, C., & Cho, C. (2013) · Journal of Biomedical Nanotechnology · doi:10.1166/jbn.2014.1682 · Cited by 18 · see citing works
Wu, L., Xie, J., Tan, L., Mai, Z., Wang, L., Wang, X., & Chen, T. (2017) · Royal Society Open Science · doi:10.1098/rsos.170822 · Cited by 17 · see citing works
Attia, N., Mashal, M., Grijalvo, S., Eritja, R., Puras, G., & Pedraz, J. L. (2019) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2019.101219 · Cited by 17 · see citing works
Self-citationOpanasopit, P., Leksantikul, L., Niyomtham, N., Rojanarata, T., Ngawhirunpat, T., & Yingyongnarongkul, B. (2015) · Pharmaceutical Development and Technology · doi:10.3109/10837450.2015.1125925 · Cited by 15 · see citing works
Attia, N., Mashal, M., Soto‐Sánchez, C., Martı́nez, G., Fernández, E., Grijalvo, S., Eritja, R., Puras, G., & Pedraz, J. L. (2018) · Drug Design Development and Therapy · doi:10.2147/dddt.s178532 · Cited by 15 · see citing works
Self-citationWrangling RNA: Antisense oligonucleotides for neurological disorders
Talbot, K., & Wood, M. J. A. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aay2069 · Cited by 14 · see citing works
CRISPR screens come into sight
Burgess, D. J. (2019) · Nature Reviews Genetics · doi:10.1038/s41576-019-0192-5 · Cited by 12 · see citing works
Megías, R., Arco, M., Ciriza, J., del Burgo, L. S., Puras, G., López-Viota, M., Delgado, Á. V., Dobson, J., Arias, J. L., & Pedraz, J. L. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.12.042 · Cited by 12 · see citing works
Self-citationMilani, P., Mussinelli, R., Perlini, S., Palladini, G. O., & Obici, L. P. (2019) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2019.1671352 · Cited by 11 · see citing works
Mullard, A. (2019) · Nature Reviews Drug Discovery · doi:10.1038/d41573-019-00154-0 · Cited by 9 · see citing works
Repairing the Brain: Gene Therapy
Björklund, T. (2018) · Journal of Parkinson s Disease · doi:10.3233/jpd-181485 · Cited by 7 · see citing works
Virotherapy: Current Trends and Future Prospects for Treatment of Colon and Rectal Malignancies
Lee, C. L., Veeramani, S., Molouki, A., Lim, S. E., Thomas, W., Chia, S. L., & Yusoff, K. (2019) · Cancer Investigation · doi:10.1080/07357907.2019.1660887 · Cited by 7 · see citing works
Delivery of an adenovirus vector plasmid by ultrapure oligochitosan based polyplexes
Agirre, M., Sesma, J. Z., Ojeda, E., Puras, G., Rojas, L. A., Alemany, R., & Pedraz, J. L. (2014) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2014.12.062 · Cited by 6 · see citing works
Self-citationPrimavera, R., Palumbo, P., Celia, C., Cilurzo, F., Cinque, B., Carata, E., Carafa, M., Paolino, D., Cifone, M. G., & Marzio, L. D. (2018) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2018.05.010 · Cited by 4 · see citing works
Flagged first, then by citations
1 of the 175 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Current advances in niosomes applications for drug delivery and cancer treatment
Moammeri, A., Chegeni, M. M., Sahrayi, H., Ghafelehbashi, R., Memarzadeh, F., Mansouri, A., Akbarzadeh, I., Abtahi, M. S., Hejabi, F., & Ren, Q. (2023) · Materials Today Bio · doi:10.1016/j.mtbio.2023.100837 · Cited by 199 · see citing works
Gene Therapy for Retinal Degenerative Diseases: Progress, Challenges, and Future Directions
Drag, S., Dotiwala, F., & Upadhyay, A. K. (2023) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.64.7.39 · Cited by 145 · see citing works
The involvement of immune system in intervertebral disc herniation and degeneration
Ye, F., Lyu, F., Wang, H., & Zheng, Z. (2022) · JOR Spine · doi:10.1002/jsp2.1196 · Cited by 145 · see citing works
Applications of Hyaluronic Acid in Ophthalmology and Contact Lenses
Chang, W.-H., Liu, P., Lin, M.-H., Lu, C.-J., Chou, H.-Y., Nian, C.-Y., Jiang, Y.-T., & Hsu, Y. (2021) · Molecules · doi:10.3390/molecules26092485 · Cited by 116 · see citing works
Lipid-Based Nanoformulations for Drug Delivery: An Ongoing Perspective
Rehman, M., Tahir, N., Sohail, M. F., Qadri, M. U., Duarte, S. O. D., Brandão, P., Esteves, T., Javed, I., & Fonte, P. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16111376 · Cited by 104 · see citing works
Grijalvo, S., Puras, G., Sesma, J. Z., Sainz-Ramos, M., Qtaish, N. A., López-Méndez, T. B., Mashal, M., Attia, N., Díaz, D. D., Pons, R., et al. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11020050 · Cited by 95 · see citing works
Self-citationAlexander, A., & Saraf, S. (2018) · Neural Regeneration Research · doi:10.4103/1673-5374.241458 · Cited by 77 · see citing works
How Far Are Non-Viral Vectors to Come of Age and Reach Clinical Translation in Gene Therapy?
Sainz-Ramos, M., Gallego, I., Villate-Beitia, I., Sesma, J. Z., Maldonado, I., Puras, G., & Pedraz, J. L. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22147545 · Cited by 59 · see citing works
Self-citationCurrent developments of gene therapy in human diseases
Liu, F., Li, R., Zhu, Z., Yang, Y., & Lu, F. (2024) · MedComm · doi:10.1002/mco2.645 · Cited by 43 · see citing works
Scaffold-Mediated Gene Delivery for Osteochondral Repair
Madry, H., Venkatesan, J. K., Carballo-Pedrares, N., Rey‐Rico, A., & Cucchiarini, M. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12100930 · Cited by 35 · see citing works
Next generation therapeutics for retinal neurodegenerative diseases
Appell, M. B., Pejavar, J., Pasupathy, A., Rompicharla, S. V. K., Abbasi, S., Malmberg, K., Kolodziejski, P., & Ensign, L. M. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.01.063 · Cited by 32 · see citing works
Smart Lipid‐Based Nanoparticles in Lung Cancer Treatment: Current Status and Future Directions
Shahrivar, R. Y., Fakhr, Z. A., Abbasgholinejad, E., & Doroudian, M. (2023) · Advanced Therapeutics · doi:10.1002/adtp.202300275 · Cited by 30 · see citing works
Controlled Release of rAAV Vectors from APMA-Functionalized Contact Lenses for Corneal Gene Therapy
Alvarez-Rivera, F., Rey‐Rico, A., Venkatesan, J. K., Díaz-Gómez, L. A., Cucchiarini, M., Concheiro, Á., & Alvarez‐Lorenzo, C. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12040335 · Cited by 30 · see citing works
Zakharova, L. Y., Maganova, F., Sinyashin, K. O., Gaynanova, G. A., Mirgorodskaya, A. B., Vasilieva, E. A., & Sinyashin, O. G. (2023) · Russian Journal of General Chemistry · doi:10.1134/s1070363223070253 · Cited by 28 · see citing works
AL Qtaish, N., Gallego, I., Paredes, A. J., Villate-Beitia, I., Soto-Sánchez, C., Martínez-Navarrete, G., Sainz-Ramos, M., Lopez-Mendez, T. B., Fernández, E., Puras, G., et al. (2022) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c02182 · Cited by 29 · see citing works
Self-citationDendrimers as Non-Viral Vectors in Gene-Directed Enzyme Prodrug Therapy
Chiş, A. A., Dobrea, C. M., Rus, L. L., Frum, A., Morgovan, C., Butucă, A., Totan, M., Juncan, A. M., Gligor, F. G., & Arseniu, A. M. (2021) · Molecules · doi:10.3390/molecules26195976 · Cited by 27 · see citing works
Bishnoi, S., Rehman, S., Dutta, S. B., De, S. K., Chakraborty, A., Nayak, D., & Gupta, S. (2021) · ACS Omega · doi:10.1021/acsomega.1c02632 · Cited by 25 · see citing works
Gallego, I., Villate-Beitia, I., del Burgo, L. S., Puras, G., & Pedraz, J. L. (2022) · Pharmacological Reviews · doi:10.1124/pharmrev.121.000418 · Cited by 25 · see citing works
Self-citationRecent Developments in Gene Therapy for Neovascular Age-Related Macular Degeneration: A Review
Finocchio, L., Zeppieri, M., Gabai, A., Toneatto, G., Spadea, L., & Salati, C. (2023) · Biomedicines · doi:10.3390/biomedicines11123221 · Cited by 28 · see citing works
Niosomes-based gene delivery systems for effective transfection of human mesenchymal stem cells
Carballo-Pedrares, N., Kattar, A., Concheiro, Á., Alvarez‐Lorenzo, C., & Rey‐Rico, A. (2021) · Materials Science and Engineering C · doi:10.1016/j.msec.2021.112307 · Cited by 23 · see citing works
Chondrogenic Differentiation of Human Mesenchymal Stem Cells via SOX9 Delivery in Cationic Niosomes
Carballo-Pedrares, N., Sanjurjo‐Rodríguez, C., Señarís, J., Díaz‐Prado, S., & Rey‐Rico, A. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14112327 · Cited by 20 · see citing works
Mashal, M., Attia, N., Grijalvo, S., Eritja, R., Puras, G., & Pedraz, J. L. (2023) · Drug Delivery · doi:10.1080/10717544.2023.2219420 · Cited by 19 · see citing works
Self-citationChemical Modifications in Nucleic Acids for Therapeutic and Diagnostic Applications
Fàbrega, C., Aviñó, A. M., & Eritja, R. (2021) · The Chemical Record · doi:10.1002/tcr.202100270 · Cited by 18 · see citing works
Self-citationMacrophage Efferocytosis as a Therapeutic Strategy in Intervertebral Disc Degeneration
Chen, S., Zhang, H., Wang, Z., Zhu, D., Li, Y., Zhang, Y., Wang, D., Chen, S.-W., Liu, H., & Kang, X. (2025) · Cell Proliferation · doi:10.1111/cpr.70068 · Cited by 15 · see citing works
de Oliveira, F. A., Albuquerque, L. J. C., Delecourt, G., Bennevault, V., Guégan, P., & Giacomelli, F. C. (2021) · Current Gene Therapy · doi:10.2174/1566523221666210705130238 · Cited by 15 · see citing works
Saharawat, S., & Verma, S. (2024) · Current Drug Delivery · doi:10.2174/0115672018269199231121055548 · Cited by 15 · see citing works
Efficient Gene Delivery Based on Guanidyl‐Nucleic Acid Molecular Interactions
Wang, D., Song, J., Wang, J., Zhang, Z., Shen, Q. X., Wang, J., Guo, H., Wang, R., Xie, C., Lu, W., et al. (2020) · Advanced Functional Materials · doi:10.1002/adfm.202004783 · Cited by 14 · see citing works
Kattar, A., Concheiro, Á., & Alvarez‐Lorenzo, C. (2021) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2021.1953466 · Cited by 14 · see citing works
Sphingolipid extracts enhance gene delivery of cationic lipid vesicles into retina and brain
Qtaish, N. A., Gallego, I., Villate-Beitia, I., Sainz-Ramos, M., Martı́nez, G., Soto‐Sánchez, C., Fernández, E., Gálvez‐Martín, P., López-Méndez, T. B., Puras, G., et al. (2021) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2021.09.011 · Cited by 13 · see citing works
Self-citationEş, İ., Thakur, A., Khaneghah, A. M., Foged, C., & de la Torre, L. G. (2024) · Biotechnology Advances · doi:10.1016/j.biotechadv.2024.108342 · Cited by 13 · see citing works
Drug Encapsulation: Review of Niosomes for Promoting Antimicrobial Activity
do Nascimento, T., Garófalo, D. D. A., Monteiro, M. S. D. S. D. B., Santos‐Oliveira, R., Matos, A. P. D. S., & Ricci‐Júnior, E. (2022) · Journal of Nanoparticle Research · doi:10.1007/s11051-022-05637-7 · Cited by 11 · see citing works
Sainz-Ramos, M., Villate-Beitia, I., Gallego, I., Qtaish, N. A., Menéndez, M., Lagartera, L., Grijalvo, S., Eritja, R., Puras, G., & Pedraz, J. L. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13111787 · Cited by 10 · see citing works
Self-citationPhotosensitive Poly-l-lysine/Heparin Interpolyelectrolyte Complexes for Delivery of Genetic Drugs
Korzhikov-Vlakh, V. A., Katernuk, I., Pilipenko, I., Lavrentieva, A. V., Guryanov, I., Sharoyko, V. V., Manshina, A., & Tennikova, T. B. (2020) · Polymers · doi:10.3390/polym12051077 · Cited by 10 · see citing works
López-Seijas, J., Iglesias-Fente, A., Miranda-Balbuena, D., & Rey‐Rico, A. (2025) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2025.106766 · Cited by 9 · see citing works
Sultana, S., Yusuf, M., & Sharma, V. (2025) · AAPS PharmSciTech · doi:10.1208/s12249-025-03159-8 · Cited by 9 · see citing works
Development of new non-viral systems for genetic modification of senescent cells
López-Seijas, J., Miranda-Balbuena, D., Iglesias-Fente, A., Sacristán-Santos, M., Carballo-Pedrares, N., Arufe, M. C., Rey‐Rico, A., & Fafián‐Labora, J. (2023) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2023.03.010 · Cited by 9 · see citing works
Non-Viral Delivery Systems to Transport Nucleic Acids for Inherited Retinal Disorders
Jony, M. J. H., Joshi, A., Dash, A. K., & Shukla, S. (2025) · Pharmaceuticals · doi:10.3390/ph18010087 · Cited by 10 · see citing works
Elegant, Flexible Vesicular Nanocarriers for the Efficient Skin Delivery of Topically Applied Drugs
Albalawi, W. I., Alharbi, S., Alanazi, F., Alahmadi, H., Alghamdi, M., Soliman, G. M., & Safwat, M. A. (2021) · Current Nanoscience · doi:10.2174/1573413718666211230111538 · Cited by 8 · see citing works
Intravitreal CBD-loaded niosomes enhance retinal neuroprotection in ischemic injury
da Silva, C. N., Dourado, L. F. N., Agata, B. L., Fernandes, M. A. S., Dias, M. F., & Fialho, S. L. (2025) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2025.114705 · Cited by 6 · see citing works
Qtaish, N. A., Villate-Beitia, I., Gallego, I., Martı́nez, G., Soto‐Sánchez, C., Sainz-Ramos, M., López-Méndez, T. B., Paredes, A. J., Chichón, F. J., Zamarreño, N., et al. (2023) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2023.122968 · Cited by 6 · see citing works
Self-citationSánchez-Martos, M. Á., Martı́nez, G., Bernabeu-Zornoza, A., Humphreys, L., & Fernández, E. (2021) · Nanomaterials · doi:10.3390/nano11071756 · Cited by 5 · see citing works
Self-citationA Comprehensive Review on Recent Advances and Patents of Niosomes
Saharawat, S., & Verma, S. (2023) · Recent Patents on Nanotechnology · doi:10.2174/0118722105259776231002071218 · Cited by 4 · see citing works
Javanmard, Z., Pourhajibagher, M., & Bahador, A. (2023) · Infectious Disorders - Drug Targets · doi:10.2174/1871526523666230724120957 · Cited by 3 · see citing works
do Nascimento, T., Cardoso, V. D. S., Santos‐Oliveira, R., Barreto-Vieira, D. F., Vermelho, A. B., & Ricci‐Júnior, E. (2025) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2025.107243 · Cited by 2 · see citing works
Nanovesicles for intravenous drug delivery
Gülteki̇n, H. E., Öner, E., İlhan, M., & Karpuz, M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-91865-7.00018-3 · Cited by 2 · see citing works
Bhagawan, W. S., Annisa, R., & Maulidya, A. F. (2021) · Journal of Pharmaceutical Sciences and Community · doi:10.24071/jpsc.002839 · Cited by 1 · see citing works
Al‐Saffar, A. Z., Mohammed, H. A., Khan, R. A., Sulaiman, G. M., Hadi, N. A., Ismaeel, F. E., Mostafa, E. M., Khashan, K. S., & Ismail, A. (2025) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2025.107822 · Cited by 1 · see citing works
Preparation and Characterization of Niosomes for Bacteriophage Delivery
George, A. H., Jelínek, P., Benešík, M., Košiarčiková, S., Mikšátko, J., Pečurlić, I., Moša, M., & Šoóš, M. (2025) · Small Science · doi:10.1002/smsc.202500530 · Cited by 1 · see citing works
Recent advances in lipid and biomimetic nanocarriers for nucleic acid delivery in glioblastoma
Xu, C., He, Z., & Li, J. (2026) · Discover Oncology · doi:10.1007/s12672-026-04991-5 · Cited by 1 · see citing works
Hydrogels as biologics/gene delivery systems
Rey‐Rico, A., Carballo-Pedrares, N., Venkatesan, J. K., Madry, H., & Cucchiarini, M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-823948-3.00034-8 · Cited by 1 · see citing works
A novel gene delivery approach to face cystic fibrosis by non-viral vectors based on niocarbosomes
Maldonado, I., Gallego, I., Enríquez, L., Iturrospe, A., Arbe, A., Mashal, M., Attia, N., Puras, G., & Pedraz, J. L. (2025) · Surfaces and Interfaces · doi:10.1016/j.surfin.2025.106639 · Cited by 1 · see citing works
Self-citationHatem, S. J., Al-Tu’ma, F. J., & Mukheef, M. A. (2024) · Research Square · doi:10.21203/rs.3.rs-4767562/v1 · Cited by 1 · see citing works
Vaithilingam, V., Reys, L. L., Sthijns, M. M. J. P. E., Rademakers, T., de Vries, R. H. W., Mohammed, S. G., Bont, D. D., Jetten, M., de Koning, E. J. P., Mourad, N. I., et al. (2022) · Tissue Engineering Part A · doi:10.1089/ten.tea.2022.29025.abstracts
Fabiano, M. G., Forte, J., Hanieh, P. N., Rinaldi, F., Marianecci, C., & Carafa, M. (2024) · Springer eBooks · doi:10.1007/978-3-031-59478-6_3
Goyal, S., & Vanita, V. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-43986-5.00042-4
Discoradicular conflict: vicious circles of the inflammatory model
Kovalev, M. A., Sherman, M. A., Муравьев, С. В., Зурабиевна, К. Г., & Дмитриевич, Ш. И. (2026) · Perm Medical Journal · doi:10.17816/pmj43334-49
Iglesias-Fente, A., López-Seijas, J., Arufe, M. C., Fafián‐Labora, J., & Rey‐Rico, A. (2026) · Drug Delivery · doi:10.1080/10717544.2026.2726650
- Authors
- AL Qtaish, N., Gallego, I., Villate-Beitia, I., Sainz-Ramos, M., López-Méndez, T. B., Grijalvo, S., Eritja, R., Soto-Sánchez, C., Martínez-Navarrete, G., Fernández, E., Puras, G., & Pedraz, J. L.
- Affiliations
- NanoBioCel group, University of the Basque Country (UPV/EHU), E-01006 Vitoria-Gasteiz, Spain
- University of the Basque Country (ES)
- Biomedical Research Networking Center in Bioengineering, Biomaterials and Nanomedicine (ES)
- Neuroprothesis and Neuroengineering Research Group, Miguel Hernández University, E-03202 Elche, Spain
- Universitat de Miguel Hernández d'Elx (ES)
- Corresponding author
- Puras, Gustavo
- ORCID
- Venue
- Pharmaceutics
- Publisher
- MDPI AG
- Published
- 2020-02-25
- Volume
- 12
- Issue
- 3
- Pages
- 198
- ISSN
- 1999-4923 (ISSN-L)
- PMC
- PMC7150807
- OpenAlex
- W3006910022
- Cited by
- 57
- References
- 175
- Citations by year
- 2026: 4 · 2025: 9 · 2024: 7 · 2023: 11 · 2022: 7 · 2021: 13 · 2020: 4 · 2019: 1 · 2018: 1
- FWCI
- 0.84
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- Pharmaceutics (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Communities in ADDI (University of the Basque Country) (submittedVersion, cc-by)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Hispana (submittedVersion, cc-by)
- Funders
- Grupos consolidados (IT907-16)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Keywords
- niosomes, non-viral gene delivery, cationic lipids, nonionic surfactants, retina, cerebral cortex, targeted gene delivery, non-viral vectors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review